Target intelligence / Profile preview

Ras converting CAAX endopeptidase 1 (RCE1)

Target
RCE1
Molecular classification
Enzyme, Intramembrane protease (IMP), Metalloproteinase family
01

Overview

Ras converting CAAX endopeptidase 1 (RCE1) is an integral membrane enzyme located in the endoplasmic reticulum that functions as an intramembrane metalloproteinase. It cleaves the C-terminal tripeptide ("-AAX") from prenylated proteins containing a CAAX motif, including the Ras family of small GTPases, nuclear lamins, and various protein kinases and phosphatases. This post-translational modification is essential for correct localization and function of these proteins, many of which are involved in key cellular signaling pathways. Disruption of RCE1 activity affects multiple signaling proteins and has been linked to cancer and other diseases, making RCE1 a potential therapeutic target under active investigation[1][2][3][5].

Other names
CAAX prenyl protease 2FACE2FACE-2FACE2_HUMANhRCE1RCE1ARCE1BFarnesylated proteins-converting enzyme 2Prenyl protein-specific endoprotease 2RCE1 homologPrenyl protein peptidaseType II CAAX prenyl endopeptidase
02

Mechanism of action

Inhibition of RCE1 disrupts cleavage of CAAX motif, leading to mislocalization and impaired function of Ras and other prenylated proteins

03

Biological functions

Post-translational processing of CAAX motif-containing proteinsRemoval of C-terminal tripeptides from prenylated proteinsProtein maturationRegulation of protein localizationCell signaling
04

Disease associations

Cancer (primarily due to effects on Ras and other prenylated proteins)CardiomyopathyMyeloproliferative diseaseRetinal degenerationLaminopathies (e.g., Mandibuloacral dysplasia, Restrictive dermopathy)
05

Safety considerations

Potential for broad, pleiotropic effects due to global impact on prenylated proteinsCardiotoxicity (cardiomyopathy in animal models)Hematologic effects (exacerbation of myeloproliferative disease)Retinal degeneration observed in knockout models
06

Interacting drugs

8-hydroxyquinoline derivatives (experimental chemical class targeting RCE1)

1 more in the full profile.

Beyond the preview

Go deeper on Ras converting CAAX endopeptidase 1 (RCE1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ras converting CAAX endopeptidase 1 (RCE1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call